- Home
- ADXN vs NTBL Comparison
ADXN vs NTBL Comparison
Compare ADXN & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- NTBL
- Stock Information
- Founded
- ADXN 2002
- NTBL 2000
- Country
- ADXN Switzerland
- NTBL United States
- Employees
- ADXN N/A
- NTBL N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- NTBL Health Care
- Exchange
- ADXN Nasdaq
- NTBL Nasdaq
- Market Cap
- ADXN 11.3M
- NTBL 4.6M
- IPO Year
- ADXN N/A
- NTBL N/A
- Fundamental
- Price
- ADXN $10.30
- NTBL $0.34
- Analyst Decision
- ADXN Strong Buy
- NTBL Buy
- Analyst Count
- ADXN 1
- NTBL 2
- Target Price
- ADXN $30.00
- NTBL $5.00
- AVG Volume (30 Days)
- ADXN 22.8K
- NTBL 8.0M
- Earning Date
- ADXN 11-11-2024
- NTBL 11-12-2024
- Dividend Yield
- ADXN N/A
- NTBL N/A
- EPS Growth
- ADXN N/A
- NTBL N/A
- EPS
- ADXN 0.05
- NTBL N/A
- Revenue
- ADXN $960,641.00
- NTBL $313,000.00
- Revenue This Year
- ADXN N/A
- NTBL N/A
- Revenue Next Year
- ADXN N/A
- NTBL N/A
- P/E Ratio
- ADXN $1.75
- NTBL N/A
- Revenue Growth
- ADXN N/A
- NTBL 3812.50
- 52 Week Low
- ADXN $5.00
- NTBL $0.22
- 52 Week High
- ADXN $27.90
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- ADXN 54.08
- NTBL 43.04
- Support Level
- ADXN $10.04
- NTBL $0.28
- Resistance Level
- ADXN $10.81
- NTBL $0.67
- Average True Range (ATR)
- ADXN 0.59
- NTBL 0.06
- MACD
- ADXN 0.04
- NTBL -0.00
- Stochastic Oscillator
- ADXN 70.88
- NTBL 27.53
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.